Revenue | ₹38.47Cr |
Net Profits | ₹6.51Cr |
Net Profit Margins | 16.92% |
Jenburkt Pharmaceuticals Ltd’s revenue jumped 3.94% since last year same period to ₹38.47Cr in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -10.68% fall in its revenue since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit jumped 20.56% since last year same period to ₹6.51Cr in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -32.19% fall in its net profits since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit margin jumped 15.98% since last year same period to 16.92% in the Q3 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated -24.08% fall in its net profit margins since last 3-months.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was ₹38.47Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was ₹6.51Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q3 results 2024 was 16.92%.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q3 results 2023 was ₹37.01Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q3 results 2023 was ₹5.40Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q3 results 2023 was 14.59%.